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Abstract Although many underlying diseases have been
reported in the setting of childhood arterial ischemic stroke,
emerging research demonstrates that non-atherosclerotic
intracerebral arteriopathies in otherwise healthy children
are prevalent. Minor infections may play a role in arterio-
pathies that have no other apparent underlying cause.
Although stroke in childhood differs in many aspects from
adult stroke, few systematic studies specific to pediatrics
are available to inform stroke management. Treatment trials
of pediatric stroke are required to determine the best
strategies for acute treatment and secondary stroke preven-
tion. The high cost of pediatric stroke to children, families,
and society demands further study of its risk factors,
management, and outcomes. This review focuses on the
recent findings in childhood arterial ischemic stroke.
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Introduction
Tremendous efforts have been made to increase public
recognition of adult stroke, yet pediatric stroke remains
under-recognized even among health care providers. How-
ever, pediatric stroke is an important cause of lifelong
disability. A recent population-based study of stroke in
children less than 20 years of age estimates an annual rate
of 2.4 arterial ischemic strokes per 100,000 children [1].
Large-scale studies of pediatric stroke have begun to
advance our understanding of underlying risk factors, but
little research is currently available to guide decision
making about acute management and secondary stroke
prevention. Many of these children are left with permanent
neurologic deficits and epilepsy, and pediatric stroke incurs
a high cost to families and societies. Although pediatric
stroke includes arterial ischemic stroke, hemorrhagic stroke,
and venous thrombosis, hemorrhage and venous thrombo-
ses are beyond the scope of this brief update.
Risk Factors for Arterial Ischemic Stroke:
The Importance of Arteriopathies
Overall, presumptive risk factors for arterial ischemic stroke
differ in children compared with adults. Whereas adult risk
factors are primarily related to arrhythmias and obstructive
atherosclerotic arteriopathies, these are rarely thought to be
related to stroke in children. Also in contrast to adults,
socioeconomic status has not been shown to be associated
with an increased stroke risk in children [2]. Interestingly,
just as gender differences are found in adult stroke studies,
several pediatric studies have shown a male predominance
in children with a stroke [2, 3]. Among boys, elevated
testosterone levels were independently associated with
stroke risk [4]. The mechanism of this association is still
unknown. In the International Pediatric Stroke Study (IPSS)
and other studies of pediatric stroke, a wide range of
underlying systemic factors were reported in the setting of
childhood stroke, particularly sickle cell disease, cardiac
disorders, trauma, and major infections such as meningitis,
sepsis, and encephalitis [2]. However, in the majority of the
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advances in neuroimaging, cerebral arteriopathies are
increasingly recognized as one of the major causes of
childhood stroke in otherwise healthy children [6, 7￿].
Although the importance of arteriopathies is highlighted in
this review, advances in understanding of sickle cell
disease, cardiac disease, and prothrombotic disorders are
also discussed.
Arteriopathies are an Important Underlying Cause
of Childhood Arterial Ischemic Stroke
The IPSS recently reported on presumptive risk factors in
their case series of 667 children from five continents that
have had a stroke [5]. In the study, 53% of the children who
had vascular imaging were found to have an arteriopathy
[7￿]. Some arteriopathies are due to well-recognized causes
such as arterial dissection, moyamoya syndrome or disease,
connective tissue disorders, and sickle cell disease. Late
effects of radiation to the head and neck in childhood
cancer survivors have also been associated with stroke due
to cerebrovascular disease, and children with neurofibro-
matosis can have complications of a cerebral arteriopathy
[8]. However, in up to 30% of children presenting with a
first arterial ischemic stroke, a focal arterial stenosis is
identified but none of the classic underlying causes are
discovered.
The term “transient cerebral arteriopathy” (TCA) was
first used to describe a common course of cerebrovascular
pathology in a group of children with ischemic stroke who
received serial imaging studies [9]. In this group, focal
stenoses or segmental narrowing of the cerebral arterial
wall, characteristically involving the distal internal cerebral
artery, proximal middle cerebral artery, and sometimes the
proximal anterior cerebral artery, were followed over time
with serial angiograms (Fig. 1). The term “transient” was
used because of the monophasic progression of cerebro-
vascular disease. In children with TCA, the arterial stenosis
and narrowing is strictly unilateral and may initially
worsen. In some cases, no abnormality is noted on initial
vascular imaging, but stenosis or occlusion is seen on
follow-up imaging within the first few months. However,
after the first 6 months, the arteriopathy stabilizes and
sometimes improves. In some sense, the term “transient”
cerebral arteriopathy is somewhat misleading. Although
monophasic in the progression of stenosis, in many cases
the arterial narrowing persists on long-term follow-up
imaging.
On initial imaging studies, TCA cannot be distinguished
from a progressive arteriopathy such as moyamoya disease
or a vasculitis that presents unilaterally. Worsening after
6 months or bilateral involvement suggests an arteriopathy
other than TCA, with a different course and prognosis. In
recognition of the limitations of classifying arteriopathies
on initial imaging, the IPSS has recently suggested the term
“focal cerebral arteriopathy” of childhood (FCA) to
describe children with unilateral arterial stenosis without
an apparent underlying cause at presentation [7￿]. Both the
terms TCA and FCA are simply descriptive and do not
imply a specific pathophysiology; however, these arterio-
pathies are clinically important because they indicate an
increased risk for recurrent stroke [6, 10, 11]. In all children
who have had a stroke, vascular imaging of intracranial and
neck vessels is imperative to detect arteriopathies, with
magnetic resonance angiography (MRA) as the preferred
modality. However, if interventional neuroradiologists who
have an expertise in pediatrics are available, conventional
angiography can be considered in cases in which diagnosis
remains unclear on MRA. In addition, even in children with
a stable clinical course, MRI and vascular imaging should
be repeated 3–6 months after the acute stroke and again
1 year later to detect development of or changes in
arteriopathies, as well as to look for new subclinical
infarcts.
Recent Infection is a Risk Factor for Focal Cerebral
Arteriopathy in Childhood
Currently, the underlying mechanisms for these unilateral,
monophasic arteriopathies are poorly understood, and
studies are ongoing to elucidate their pathophysiology.
The role of infection as a part of the underlying vascular
pathology is of particular current interest. The link between
childhood stroke and infection was first noted because of its
Fig. 1 A magnetic resonance angiography (MRA) image taken
7 months after a stroke in a 7-year-old girl demonstrates a persistent,
stable, unilateral stenosis of the left proximal middle cerebral artery.
This imaging is typical of “transient cerebral arteriopathy,” a mono-
phasic focal cerebral arteriopathy observed in many previously healthy
children with stroke. The stenosis shown in this image (arrow) was
essentially unchanged from the MRA done acutely after the stroke
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angiopathy has been well described as a cause for ischemic
stroke in both adults and children [12, 13]. Importantly, no
association has been found with varicella vaccination [14].
Multiple viruses other than varicella have been linked to
case reports of arteriopathies and stroke in children.
Strengthening the infectious hypothesis, the IPSS reported
finding an association between childhood arteriopathies and
recent minor infections in their large cohort of children with
ischemic stroke [7￿]. In the study, 25% of the children were
classified as having FCA, higher in frequency than either
moyamoya (22%) or dissection (20%). Predictors of overall
arteriopathies were early school age (5–9 years), recent
upper respiratory infections, and sickle cell disease. The
only predictor of FCA was a recent upper respiratory
infection (odds ratio [OR]=2.1; 95% CI, 1.01–4.38). The
role of minor infections in the pathogenesis of stroke has
been suggested either as a cause of direct vascular injury, or
by inducing a systemic prothrombotic state, or through both
mechanisms. However, minor infections are extremely
common in young children, and yet most children do not
have strokes. More study is needed to clarify how infection
contributes to arteriopathies and stroke.
Transcranial Doppler Screening Effectively Reduces Stroke
Risk in Children with Sickle Cell Disease, but Barriers
to Care Persist
Children with sickle cell disease comprise another impor-
tant group with a high risk of arteriopathies and stroke.
Prior to modern primary prevention strategies, up to 11% of
children with sickle cell anemia had a clinical stroke by the
age of 20 years [15]. In 1992, transcranial Doppler (TCD)
was found to be effective in identifying patients with sickle
cell disease at high risk for stroke [16]. The Stroke
Prevention Trial in Sickle Cell Anemia (STOP) established
that chronic transfusion decreased the risk of stroke by 90%
in children with abnormal TCD results [17], leading to
recommendations for chronic transfusion for prevention of
stroke in children deemed at high risk. However, TCD
screening in sickle cell disease continues to be examined
for feasibility and efficacy internationally [18, 19], and
barriers to care persist. A recent study of children in
northern California showed the rate of stroke in children
with sickle cell disease has dropped by more than half the
rate prior to 1998, but also demonstrated that children
living farther from a vascular laboratory are less likely to be
screened [20]. Finally, although stroke risk in people with
sickle cell disease is usually attributed to red cell sickling
and vasculopathy of large intracranial vessels, new con-
cerns have recently been raised for an increased risk for
cardioembolic stroke in these children because of the
potential for increased right heart pressure and right-to-left
shunting in the setting of a prothrombotic state [21].This
suggests the intracardiac shunts in children with sickle cell
disease should be further studied as a potentially modifiable
cause of stroke. Current American Heart Association stroke
prevention screening recommendations in sickle cell dis-
ease are for annual TCD monitoring of children with
normal TCD velocities (≤170 cm/s), with consideration of
more frequent monitoring in children 2 to 10 years of age.
Children with velocities elevated to ≥200 cm/s should be
restudied in 1 month, and studies with borderline or mildly
abnormal results should be repeated in 3–6m o n t h s .
Periodic transfusions to reduce the percentage of sickle
hemoglobin are recommended in children with abnormal
TCD results [22￿￿].
Complex Congenital Heart Disease Presents Risk for Stroke
in the Peri-Operative Period, but Stroke Risk Persists
for Many Years After Surgery
Congenital heart disease and other cardiac problems are
still recognized as presumed risk factors for childhood
stroke because of their high frequency in case series [2].
A case-control study of children in northern California
demonstrated an increased risk for children with congen-
ital heart disease requiring surgical repair (OR=11; 95%
CI, 3.1–39.4) (Fox and Fullerton, unpublished data). Even
with modern surgical techniques, the peri-operative period
m a yb eo fp a r t i c u l a r l yh i g hr i s k ,a sd e m o n s t r a t e di na
recent series of 122 children undergoing open heart
surgery, which identified stroke in 10% [22￿￿]. However,
children with complex congenital heart disease remain at
risk for years after their last surgery, which reflects
increased stroke risk from the heart disease itself. When
feasible, complex congenital heart lesions should be
repaired to improve cardiac function and reduce the risk
of subsequent stroke [22￿￿].
Prothrombotic Disorders Increase the Risk of Stroke
in the Setting of Additional Risk Factors
Finally, controversies remain over the strength of associa-
tion of hypercoaguable disorders as a risk for childhood
stroke. Homozygosity for MTHFR C677T polymorphism
did not show an increased risk for arterial ischemic stroke
in two recent studies of stroke in children in the United
States [24] and Croatia [25], but a study in Poland [26]
found a threefold increased risk of stroke with the presence
of the MTHFR C677T allele. Factor V G1691A was
associated with a sevenfold increased risk among children
with stroke in the Croatian study [25]. Although various
coagulation abnormalities have been reported in children
after stroke, most pediatric stroke experts believe the
likelihood of stroke from most prothrombotic states seems
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in the setting of additional risk factors. Children with a
stroke who are found to have a prothrombotic polymor-
phism or other prothrombotic state should have additional
workup including serial vascular imaging to determine
etiology. Although there are no class I recommendations
regarding hypercoaguable states in childhood stroke, it is
reasonable to evaluate for elevated serum homocysteine
levels and the more common prothrombotic states, and start
folate, vitamin B6, or vitamin B12 if homocysteine is found
to be elevated. It is also reasonable to discontinue oral
contraceptives in adolescents after an ischemic or throm-
botic stroke [22].
Management of Pediatric Stroke: Need
for Further Study
Acute management of children with stroke is primarily
supportive, including control of fever, blood pressure
normalization to accepted age ranges, normalization of
glucose, and maintenance of normal oxygenation. For
secondary stroke prevention, the majority of children are
treated with either anticoagulation or antiplatelet therapies,
and current practice varies widely. Overall, the great variety
of treatment strategies emphasizes the need for better
evidence and clinical trials to guide management of
childhood stroke.
Antiplatelet Agents or Anticoagulation are Used
for Secondary Stroke Prevention
Of the children enrolled in the IPSS who had a non-
neonatal arterial ischemic stroke, 27% of children were
treated with anticoagulation alone, 28% were treated with
antiplatelet therapy alone, and 16% were treated with both
anticoagulation and antiplatelet therapies [27]. Predictors of
anticoagulation were dissection and cardiac disease. This
parallels recent American Heart Association guidelines
[22￿￿] and American College of Chest Physicians guide-
lines [28￿￿] for consideration of anticoagulation in children
in the setting of confirmed cardio-embolism or arterial
dissection. Because the risk for recurrence is relatively high
in children who have arteriopathies, there has been some
interest in exploring the safety of anticoagulation in this
setting. A nonrandomized, unblinded study from the
Colorado and German (COAG) collaboration examined
both therapeutic and prophylactic dosing of anticoagulation
therapy for stroke in children with non-moyamoya arterio-
pathy, with only two clinically relevant bleeding episodes
in 1329 patient-months [11]. The relatively low risk of
bleeding suggests that anticoagulation could be safely
studied in future trials.
Clinical Trials are Required Before Tissue Plasminogen
Activator is Used for Acute Stroke Treatment
in Younger Ages
Although tissue plasminogen activator (tPA) has changed
the face of adult stroke treatment, there have been no
randomized controlled trials of therapeutics in childhood
arterial ischemic stroke. A special writing group of the
American Heart Association Stroke Council and the
Council on Cardiovascular Disease in the Young has
recently published an extensive review of the literature on
childhood stroke with consensus guidelines for the man-
agement of stroke in infants and children [22￿￿]. In that
review, there was no consensus about the use of tPA in
older adolescents who otherwise met standard adult tPA
eligibility criteria. In younger children, tPA was not
recommended outside of a clinical trial. In the IPSS
observational cohort of children with acute arterial ischemic
stroke, 2% of the children received either intravenous or
intra-arterial tPA, at a median time of 3.3 h or 4.5 h,
respectively. Of these 15 patients, new or increased
intracerebral hemorrhage was found in four, and the
recurrent stroke rate at 1 year was 14% [29]. In addition,
a recent literature review described a series of 17 children
who had received intravenous, intra-arterial, or mechanical
thrombolysis for large vessel strokes; 16 children survived
and 12 had a good outcome [30].
Delay in Pediatric Stroke Recognition is a Barrier
to Efficient Care and Future Stroke Trials
The appropriate dosage of tPA in various age groups
remains an unknown, and extrapolation from adult data is
complicated by age-related differences in coagulation
systems. Thus far, there are no systematic data to guide
the age-appropriate use of tPA in children, and clinical trials
are needed to explore safety and efficacy in this population.
The Thrombolysis in Pediatric Stroke (TIPS) trial is in
planning stages; it aims to test the hypothesis that tPA can
be given safely in acute childhood arterial ischemic stroke
and establish dosing guidelines [31]. However, conducting
a clinical trial in a vulnerable population can present
significant challenges. In addition, because few pediatric
strokes are diagnosed quickly enough to consider a
thrombolytic agent, trials of acute intervention may have
slow accrual. Although public health campaigns have
successfully raised awareness about stroke in adults,
awareness of pediatric stroke remains limited. Children
often present late to medical care, and even after medical
evaluation have significant delays in diagnosis. Although
the majority of children with stroke present with focal
findings such as hemiparesis [32], nonspecific presenting
signs such as altered mental status, seizure, and headache
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arterial ischemic stroke (excluding neonatal stroke) in
Australia found a median time of greater than 24 h after
clinical onset before radiologic confirmation of diagnosis
[32]. In this study, only 6.8% of the children were
diagnosed with a stroke within 3 h. In the United Kingdom
[33], Canada [34], and the United States [35], similar time
delays have been reported. Nonspecific presentation and the
perception that childhood stroke is rare both contribute to
initial misdiagnoses that result in delays in management.
Raising awareness of pediatric stroke is crucial to improv-
ing overall care of these children.
Outcomes: The High Cost of Pediatric Stroke
Pediatric stroke is an important cause of childhood
morbidity and lifelong disability, including motor and
sensory impairments, cognitive deficits, and epilepsy. In
the IPSS cohort, after arterial ischemic stroke 74% of
patients had neurologic deficits at hospital discharge and
3% of the children had died [27]. Long-term outcomes for
children in the IPSS are not yet available. Although
physical, occupational, and speech therapies are mainstays
to improve function in children with neurologic deficits
after a stroke, pediatric-specific research regarding different
methods of rehabilitation is lacking.
Children with Arteriopathies Maybe at Elevated Risk
for Recurrent Stroke
Overall, clinical stroke recurrences are seen in an
estimated 6–15% of children after a first arterial
ischemic stroke, but the risk of recurrence depends on
stroke etiology. Braun et al. [36￿] described a series of
79 children found to have an intracranial unilateral
arteriopathy after a stroke. In 74 of the children, the
arteriopathy stabilized or improved and was categorized
as TCA, although 77% of these had residual vascular
abnormalities. Recurrent stroke or transient ischemic
attack occurred in 18% of the children categorized as
TCA after a median follow-up of 1.4 years. Progressive
arteriopathies were associated with recurrence (OR=18.7;
95% CI, 1.9–182). In the COAG cohort, children with
non-moyamoya arteriopathies were given various treat-
ments of prophylactic or therapeutic anticoagulation, and
cumulative probability of recurrent stroke was 14% at
1 year [11]. These recent findings build on prior studies
that found abnormal vascular imaging predicts recurrence
[6]. Systematic studies of secondary stroke prevention in
children with arteriopathies are not yet available, and
clinical trials are needed to determine the best treatment
strategies.
Epilepsy Maybe Frequent After Childhood Stroke
In comparison with the low risk of epilepsy after stroke in
adults, estimated at 2–4% [37], the risk of epilepsy after
childhood stroke maybe an order of magnitude higher, with
some estimates as high as 67% after a neonatal stroke [38].
Follow-up studies of stroke later in childhood give
estimates of epilepsy ranging from 25 to 30% [39].
Although the frequency of epilepsy after childhood stroke
reported in these case series is worrisome, the estimates of
post-stroke epilepsy prevalence are wide ranging and there
are few data regarding predictors of epilepsy to alert
physicians to high-risk groups. More research is required
to determine the incidence and predictors of epilepsy in
these children.
Epilepsy after pediatric stroke is particularly worrisome
because of the additional morbidities reported in children
who have seizures after brain injury. After a stroke, children
are already at risk for behavioral and psychiatric problems
[40]. In turn, attention deficit hyperactivity disorder
(ADHD) can further impair school performance, particular-
ly in children whose cognitive functioning may already be
compromised. Recent studies have suggested that children
with epilepsy after a childhood stroke maybe at particular
risk for behavioral and psychiatric co-morbidities such as
ADHD and depression, and it may herald worse neuro-
cognitive outcomes [41, 42]. Some researchers theorize that
seizures after a stroke in the developing brain may change
the brain’s capacity for plasticity. However, it is not known
whether the risk for poor behavioral and cognitive out-
comes that we have begun to recognize in these children
maybe due to presence of seizures, the medications to treat
the seizures, or whether the seizures are simply a marker of
inherent capacity in children with more severe brain injury.
Quantitative Imaging Techniques may Provide Better
Prognostication of Stroke Outcomes in the Future
Infarct size and altered mental status at presentation predict
long-term outcome of pediatric stroke [27, 43, 44].
However, these broad measures still leave physicians and
families with little to guide their expectations for the future.
Children with neonatal stroke may not manifest hemiparesis
until months after birth, and a few studies have focused on
finding earlier predictors of outcome. One study of 13
children after a neonatal stroke examined hand movements
at 3 months of age. The study found asymmetric hand
movements could be determined with good inter-observer
agreement, and it predicted later hemiplegia in 13 children
[45]. Researchers are also studying imaging techniques as a
way to provide earlier prognostication. Novel imaging
techniques using measurements of diffusion MRI found
pre-Wallerian degeneration of corticospinal tracts to be
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pediatric [47] stroke. Although these diffusion-weighted
imaging quantification techniques are not yet routinely
used, in the future similar imaging techniques may provide
better prognostication. A more accurate assessment of
outcome at early time points after a childhood stroke would
be helpful both for family expectations and for selection of
patients in trials of therapeutic interventions.
Childhood Stroke is Associated with High Costs
of Medical Care
In terms of the economic burden of stroke care, adult
stroke has been analyzed extensively for cost-
effectiveness of interventions. A 2009 review of 120 cost
studies of adult ischemic and hemorrhagic stroke from 15
countries found the mean cost of adult stroke was
$19,018, but varied as much as 20-fold in the United
States estimates [48]. In contrast, fewer studies have
examined the cost of pediatric stroke. Two recent studies
have estimated acute and long-term costs of childhood
stroke in 2003 dollars. The mean cost of acute hospital
care for pediatric stroke was high, estimated at $20,927
per discharge in 2003 using a national database of ICD-9
codes (the Kids’ Inpatient Database) for both ischemic and
hemorrhagic stroke [49]. Hemorrhagic stroke, geographic
data, urban teaching hospitals, and discharge disposition
were predictors of higher cost. In a Northern California
health maintenance organization, the average coast of a
childhood acute stroke admission was $90,693 for hemor-
rhagic stroke and $36,073 for ischemic stroke. In the same
cohort, the average cost of birth admission for a neonatal
stroke was $39,613 [50]. When costs were adjusted for a
stroke-free birth admission, cost of the stroke was
estimated to account for 88% of the admission cost. In
addition, direct medical costs for inpatient and outpatient
health services over 5 years were estimated to be $51,719
for neonatal stroke and $135,161 overall in the Northern
California cohort. These studies suggest that the financial
cost of pediatric stroke is high, and that the economic
burden of medical care for these children continues for
many years after the acute hospitalization.
Conclusions
Childhood arterial ischemic stroke differs from adult stroke
in risk factors, etiologies, and outcomes. Recent studies
have focused attention on the importance of non-
atherosclerotic arteriopathies and recent infection. Although
the causes of pediatric stroke are very different from adult
stroke, many of the current therapeutic strategies and
secondary stroke prevention with antiplatelets or antico-
agulation are adapted from adult stroke management. Little
is known about the safety and efficacy of acute thrombo-
lytic therapies in various age groups. Finally, long-term
outcomes of pediatric stroke are difficult to predict, but
overall place a large burden on stroke victims, families, and
society. Further study is greatly needed for a better
understanding of the pathogenesis, management, and out-
comes in childhood arterial ischemic stroke.
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